Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods Inc. filings document the regulatory record for an Illinois operating company whose common stock trades on the Nasdaq Global Market under the symbol LWAY. Its Form 8-K reports cover operating results, sales estimates, Regulation FD disclosures, material agreements, director appointments and resignations, and compensatory arrangements under the company's 2022 Omnibus Incentive Plan.
Proxy materials describe annual shareholder meeting matters, board and committee governance, executive compensation and equity-plan administration. The filing record also identifies the company's registered securities, including common stock and preferred stock purchase rights, and includes formal disclosures related to financial reporting, governance changes and capital-structure matters.
Lifeway Foods director Jason Scher has filed Form 144, indicating his intention to sell 8,200 shares of common stock with an aggregate market value of $198,604 through Morgan Stanley Smith Barney LLC. The planned sale is scheduled for June 26, 2025, on the NASDAQ exchange.
The shares to be sold were acquired through multiple compensation-based private acquisitions from the issuer between 2019-2021, including:
- 1,648 shares on June 15, 2019
- 1,647 shares on June 15, 2020
- 2,740 shares on June 20, 2020
- 1,647 shares on June 15, 2021
- 518 shares on June 20, 2021
The filing indicates that Scher has not sold any company securities in the past three months and affirms no knowledge of undisclosed material adverse information regarding Lifeway Foods' operations. The company currently has 15,203,241 shares outstanding.
Lifeway Foods announced a Separation Agreement with former executive Amy Feldman on June 16, 2025. The agreement includes significant compensation and equity arrangements:
- A lump sum payment of $555,313.13, subject to statutory deductions
- Immediate vesting of 7,875 restricted stock units
- Vesting of 5,448 performance stock units under the 2022 Omnibus Incentive Plan
The agreement includes a comprehensive release of claims by Feldman and confirms that no additional compensation or benefits will be provided beyond those specified. The settlement fulfills all obligations under Feldman's original executive employment agreement from October 31, 2018. This material event follows her previously reported termination announced in March 2025.